Mannatech Inc (MTEX) 23.89 $MTEX
Mannatech awarded 100th patent in markets around the globe
M2 - Wed Feb 11, 7:00AM CST
Healthcare company Mannatech (NASDAQ:MTEX) disclosed on Wednesday the receipt of its 100th patent under its unique formulations in major global markets.
MTEX: 23.89 (+0.69)
Mannatech Announces 100th Patent
Business Wire - Wed Feb 11, 5:00AM CST
Mannatech, Incorporated (NASDAQ:MTEX), the founder of the M5M(SM) (Mission 5 Million(SM)) social entrepreneurial movement, the pioneer of nutritional glycobiology and the global innovator of naturally sourced supplements based on Real Food Technology(R) solutions, has been issued its 100th patent, demonstrating its commitment to delivering and protecting its unique formulations in major global markets.
MTEX: 23.89 (+0.69)
Mannatech Receives 99th Patent
Business Wire - Mon Feb 02, 5:00AM CST
Mannatech, Incorporated (NASDAQ: MTEX), the founder of the M5M(SM) (Mission 5 Million(SM)) social entrepreneurial movement, the pioneer of nutritional glycobiology and the global innovator of naturally sourced supplements based on Real Food Technology(R) solutions, has been issued its 99th patent, validating and demonstrating its position as the leading developer of nutritional technology. This patent was received in Japan for its PhytoMatrix formulation, a supplement with all natural vitamins and plant-based minerals.
MTEX: 23.89 (+0.69)
Mannatech Shares Down 15.6% Since SmarTrend's Sell Call (MTEX)
Comtex SmarTrend(R) - Fri Jan 30, 10:03AM CST
SmarTrend identified a Downtrend for Mannatech (NASDAQ:MTEX) on January 6th, 2015 at $23.11. In approximately 3 weeks, Mannatech has returned 15.58% as of today's recent price of $19.51.
MTEX: 23.89 (+0.69)
Mannatech Facing Huge Headline Risk
Duane Bair - at Seeking Alpha - Fri Jan 16, 11:39AM CST
HLF: 32.78 (-0.84), NUS: 56.92 (-1.30), MTEX: 23.89 (+0.69)
Nasdaq stocks posting largest percentage decreases
AP - Thu Jan 15, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
CENX: 23.10 (-0.17), VBFC: 17.00 (-0.81), PODD: 32.00 (-0.07), FLML: 14.15 (+0.15), AXDX: 22.86 (-0.33), LPCN: 5.91 (+0.40), PEIX: 9.82 (+0.15), MTEX: 23.89 (+0.69), DWCH: 6.26 (-0.18)
Mannatech Shares Up 36.5% Since SmarTrend's Buy Recommendation (MTEX)
Comtex SmarTrend(R) - Fri Jan 02, 10:05AM CST
SmarTrend identified an Uptrend for Mannatech (NASDAQ:MTEX) on November 4th, 2014 at $19.28. In approximately 2 months, Mannatech has returned 36.55% as of today's recent price of $26.32.
MTEX: 23.89 (+0.69)
48.7% Return Seen to Date on SmarTrend Mannatech Call (MTEX)
Comtex SmarTrend(R) - Fri Dec 26, 9:18AM CST
SmarTrend identified an Uptrend for Mannatech (NASDAQ:MTEX) on November 4th, 2014 at $19.28. In approximately 2 months, Mannatech has returned 48.74% as of today's recent price of $28.67.
MTEX: 23.89 (+0.69)
Uptrend Call Working As Mannatech Stock Rises 49.2% (MTEX)
Comtex SmarTrend(R) - Thu Dec 18, 9:07AM CST
SmarTrend identified an Uptrend for Mannatech (NASDAQ:MTEX) on November 4th, 2014 at $19.28. In approximately 1 month, Mannatech has returned 49.16% as of today's recent price of $28.75.
MTEX: 23.89 (+0.69)
Mannatech Announces Official Launch in Spain
Business Wire - Mon Dec 15, 12:00PM CST
Mannatech(R), Incorporated (NASDAQ: MTEX), the pioneer of nutritional glycobiology, leading innovator of naturally-sourced supplements based on Real Food Technology(R) solutions and creator of the M5M(SM) (Mission 5 Million(SM)) social entrepreneurial movement, announced the official opening of its operations in Spain as of December 6, 2014.
MTEX: 23.89 (+0.69)
United States Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry Analytics 2014-2021 - Market to reach $21.2 billion by 2021
M2 - Mon Dec 15, 8:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/b7xlml/vitamins) has announced the addition of Plunkett Research Ltd's new report "Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.) to reach $21.2 billion by 2021. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - Aceto Corporation - Balchem Corp - Cambrex Corp - Mannatech Inc - Mead Johnson Nutrition Company - NBTY Inc - Schiff Nutrition International Inc - Sigma-Aldrich Corp - Synutra International, Inc. - USANA Health Sciences Inc For more information visit http://www.researchandmarkets.com/research/b7xlml/vitamins Source: Plunkett Research Ltd
ACET: 20.00 (+0.27), MJN: 101.89 (+2.32), CBM: 32.96 (+0.09), SIAL: 138.20 (+0.07), USNA: 101.37 (+0.53), SYUT: 5.29 (unch), MTEX: 23.89 (+0.69), BCPC: 58.18 (+0.84)
Mannatech Shares Up 45.1% Since SmarTrend's Buy Recommendation (MTEX)
Comtex SmarTrend(R) - Wed Dec 03, 11:01AM CST
SmarTrend identified an Uptrend for Mannatech (NASDAQ:MTEX) on November 4th, 2014 at $19.28. In approximately 4 weeks, Mannatech has returned 45.06% as of today's recent price of $27.96.
MTEX: 23.89 (+0.69)
Mannatech/Jason Lester completed a Great Wall of China marathon for childhood malnutrition
M2 - Tue Dec 02, 5:48AM CST
Mannatech®, Incorporated (NASDAQ: MTEX), the pioneer of nutritional glycobiology, leading innovator of naturally-sourced supplements based on Real Food Technology® solutions, and creator of the M5M (Mission 5 MillionSM) social entrepreneurial movement, announced that on October 28, 2014, ultra-endurance athlete Jason Lester officially passed the finish line of the M5M China Run.
MTEX: 23.89 (+0.69)
Herbalife And Multilevel Marketing: Signs Of Checkmate
Jonathan Brand - at Seeking Alpha - Tue Dec 02, 2:01AM CST
SBUX: 91.58 (-0.24), HLF: 32.78 (-0.84), AVP: 9.08 (+0.39), NATR: 14.18 (-0.04), NUS: 56.92 (-1.30), USNA: 101.37 (+0.53), MTEX: 23.89 (+0.69), TUP: 72.53 (+0.44), PEP: 99.13 (-1.14)
Mannatech (MTEX) Upgraded From Hold to Buy
at The Street - Fri Nov 28, 8:42AM CST
Mannatech (MTEX) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B-.
MTEX: 23.89 (+0.69)
Mannatech awarded 100th patent in markets around the globe
M2 - Wed Feb 11, 7:00AM CST
Healthcare company Mannatech (NASDAQ:MTEX) disclosed on Wednesday the receipt of its 100th patent under its unique formulations in major global markets.
MTEX: 23.89 (+0.69)
Mannatech Announces 100th Patent
Business Wire - Wed Feb 11, 5:00AM CST
Mannatech, Incorporated (NASDAQ:MTEX), the founder of the M5M(SM) (Mission 5 Million(SM)) social entrepreneurial movement, the pioneer of nutritional glycobiology and the global innovator of naturally sourced supplements based on Real Food Technology(R) solutions, has been issued its 100th patent, demonstrating its commitment to delivering and protecting its unique formulations in major global markets.
MTEX: 23.89 (+0.69)
Mannatech Receives 99th Patent
Business Wire - Mon Feb 02, 5:00AM CST
Mannatech, Incorporated (NASDAQ: MTEX), the founder of the M5M(SM) (Mission 5 Million(SM)) social entrepreneurial movement, the pioneer of nutritional glycobiology and the global innovator of naturally sourced supplements based on Real Food Technology(R) solutions, has been issued its 99th patent, validating and demonstrating its position as the leading developer of nutritional technology. This patent was received in Japan for its PhytoMatrix formulation, a supplement with all natural vitamins and plant-based minerals.
MTEX: 23.89 (+0.69)
Mannatech Shares Down 15.6% Since SmarTrend's Sell Call (MTEX)
Comtex SmarTrend(R) - Fri Jan 30, 10:03AM CST
SmarTrend identified a Downtrend for Mannatech (NASDAQ:MTEX) on January 6th, 2015 at $23.11. In approximately 3 weeks, Mannatech has returned 15.58% as of today's recent price of $19.51.
MTEX: 23.89 (+0.69)
Mannatech Facing Huge Headline Risk
Duane Bair - at Seeking Alpha - Fri Jan 16, 11:39AM CST
HLF: 32.78 (-0.84), NUS: 56.92 (-1.30), MTEX: 23.89 (+0.69)
Nasdaq stocks posting largest percentage decreases
AP - Thu Jan 15, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
CENX: 23.10 (-0.17), VBFC: 17.00 (-0.81), PODD: 32.00 (-0.07), FLML: 14.15 (+0.15), AXDX: 22.86 (-0.33), LPCN: 5.91 (+0.40), PEIX: 9.82 (+0.15), MTEX: 23.89 (+0.69), DWCH: 6.26 (-0.18)
Mannatech Shares Up 36.5% Since SmarTrend's Buy Recommendation (MTEX)
Comtex SmarTrend(R) - Fri Jan 02, 10:05AM CST
SmarTrend identified an Uptrend for Mannatech (NASDAQ:MTEX) on November 4th, 2014 at $19.28. In approximately 2 months, Mannatech has returned 36.55% as of today's recent price of $26.32.
MTEX: 23.89 (+0.69)
48.7% Return Seen to Date on SmarTrend Mannatech Call (MTEX)
Comtex SmarTrend(R) - Fri Dec 26, 9:18AM CST
SmarTrend identified an Uptrend for Mannatech (NASDAQ:MTEX) on November 4th, 2014 at $19.28. In approximately 2 months, Mannatech has returned 48.74% as of today's recent price of $28.67.
MTEX: 23.89 (+0.69)
Uptrend Call Working As Mannatech Stock Rises 49.2% (MTEX)
Comtex SmarTrend(R) - Thu Dec 18, 9:07AM CST
SmarTrend identified an Uptrend for Mannatech (NASDAQ:MTEX) on November 4th, 2014 at $19.28. In approximately 1 month, Mannatech has returned 49.16% as of today's recent price of $28.75.
MTEX: 23.89 (+0.69)
Mannatech Announces Official Launch in Spain
Business Wire - Mon Dec 15, 12:00PM CST
Mannatech(R), Incorporated (NASDAQ: MTEX), the pioneer of nutritional glycobiology, leading innovator of naturally-sourced supplements based on Real Food Technology(R) solutions and creator of the M5M(SM) (Mission 5 Million(SM)) social entrepreneurial movement, announced the official opening of its operations in Spain as of December 6, 2014.
MTEX: 23.89 (+0.69)
United States Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry Analytics 2014-2021 - Market to reach $21.2 billion by 2021
M2 - Mon Dec 15, 8:28AM CST
Research and Markets (http://www.researchandmarkets.com/research/b7xlml/vitamins) has announced the addition of Plunkett Research Ltd's new report "Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.) to reach $21.2 billion by 2021. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - Aceto Corporation - Balchem Corp - Cambrex Corp - Mannatech Inc - Mead Johnson Nutrition Company - NBTY Inc - Schiff Nutrition International Inc - Sigma-Aldrich Corp - Synutra International, Inc. - USANA Health Sciences Inc For more information visit http://www.researchandmarkets.com/research/b7xlml/vitamins Source: Plunkett Research Ltd
ACET: 20.00 (+0.27), MJN: 101.89 (+2.32), CBM: 32.96 (+0.09), SIAL: 138.20 (+0.07), USNA: 101.37 (+0.53), SYUT: 5.29 (unch), MTEX: 23.89 (+0.69), BCPC: 58.18 (+0.84)
Mannatech Shares Up 45.1% Since SmarTrend's Buy Recommendation (MTEX)
Comtex SmarTrend(R) - Wed Dec 03, 11:01AM CST
SmarTrend identified an Uptrend for Mannatech (NASDAQ:MTEX) on November 4th, 2014 at $19.28. In approximately 4 weeks, Mannatech has returned 45.06% as of today's recent price of $27.96.
MTEX: 23.89 (+0.69)
Mannatech/Jason Lester completed a Great Wall of China marathon for childhood malnutrition
M2 - Tue Dec 02, 5:48AM CST
Mannatech®, Incorporated (NASDAQ: MTEX), the pioneer of nutritional glycobiology, leading innovator of naturally-sourced supplements based on Real Food Technology® solutions, and creator of the M5M (Mission 5 MillionSM) social entrepreneurial movement, announced that on October 28, 2014, ultra-endurance athlete Jason Lester officially passed the finish line of the M5M China Run.
MTEX: 23.89 (+0.69)
Herbalife And Multilevel Marketing: Signs Of Checkmate
Jonathan Brand - at Seeking Alpha - Tue Dec 02, 2:01AM CST
SBUX: 91.58 (-0.24), HLF: 32.78 (-0.84), AVP: 9.08 (+0.39), NATR: 14.18 (-0.04), NUS: 56.92 (-1.30), USNA: 101.37 (+0.53), MTEX: 23.89 (+0.69), TUP: 72.53 (+0.44), PEP: 99.13 (-1.14)
Mannatech (MTEX) Upgraded From Hold to Buy
at The Street - Fri Nov 28, 8:42AM CST
Mannatech (MTEX) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B-.
MTEX: 23.89 (+0.69)
